BRSSX
Price
$16.53
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VSCIX
Price
$120.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

BRSSX vs VSCIX

Header iconBRSSX vs VSCIX Comparison
Open Charts BRSSX vs VSCIXBanner chart's image
MFS Blended Research Small Cap Eq R2
Price$16.53
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$120.70
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
BRSSX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRSSX vs. VSCIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSSX is a StrongBuy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. BRSSX (366M). VSCIX pays higher dividends than BRSSX: VSCIX (1.43) vs BRSSX (0.32). BRSSX was incepted earlier than VSCIX: BRSSX (9 years) vs VSCIX (27 years). BRSSX is a more actively managed with annual turnover of: 56.00 vs. VSCIX (12.00). BRSSX has a lower initial minimum investment than VSCIX: BRSSX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 32.13 vs. BRSSX (25.36). VSCIX return over 5 years is better than : 59.15 vs. BRSSX (20.81).
BRSSXVSCIXBRSSX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD10.42118.40457%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets366M151B0%
Annual Yield % from dividends0.321.4322%
Returns for 1 year25.3632.1379%
Returns for 3 years-13.487.14-189%
Returns for 5 years20.8159.1535%
Returns for 10 yearsN/A128.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis